Home › Trial NCT05420922
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC
- Trial IDNCT05420922
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorTongji Hospital
- Enrollment2000
- Start date2021-11-01
- ConditionsHepatocellular Carcinoma · Programmed Cell Death 1 · Effects of Immunotherapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.